In particular, suicide gene therapy, such as herpes simplex virus thymidine kinase (HSV-TK)/ganciclovir (GCV) suicide gene therapy, is one of the most powerful strategies with a significant prognostic advantage in the treatment of malignant gliomas 10-12. Here, TKT is linked to malignant glioma.